Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24722701 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8739039 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22053015 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL3504932 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19538266 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17634350 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17634351 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17627631 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL29381104 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1005543 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120129924-A1 | USES OF SESQUITERPENE DERIVATIVES | KWANG DONG PHARM. CO., LTD. (KR) | 2012-05-24 | — | — | US | claimed |
| EP-2331089-A2 | USES OF SESQUITERPENE DERIVATIVES | Kwang Dong Pharm. Co., Ltd. (KR) | 2011-06-15 | — | — | EP | claimed |
| WO-2010030054-A2 | USES OF SESQUITERPENE DERIVATIVES | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2010-03-18 | — | — | WO | claimed |
| EP-2331089-B1 | USES OF SESQUITERPENE DERIVATIVES | KWANG DONG PHARM CO LTD (KR) | 2015-12-16 | — | — | EP | disclosed |
| US-8481592-B2 | Uses of sesquiterpene derivatives | KWANG DONG PHARM CO., LTD. (KR) | 2013-07-09 | — | — | US | disclosed |
| US-20120129924-A1 | USES OF SESQUITERPENE DERIVATIVES | KWANG DONG PHARM. CO., LTD. (KR) | 2012-05-24 | — | — | US | disclosed |
| EP-2331089-A2 | USES OF SESQUITERPENE DERIVATIVES | Kwang Dong Pharm. Co., Ltd. (KR) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010030054-A2 | USES OF SESQUITERPENE DERIVATIVES | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2010-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129924-A1 | USES OF SESQUITERPENE DERIVATIVES | LIPC, PNLIP, FABP1 | ALOX15 120/4885ALDH1A1 975/4885LMNA 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.